Truscreen Group Ltd (TRU) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.502x

Based on the latest financial reports, Truscreen Group Ltd (TRU) has a cash flow conversion efficiency ratio of -0.502x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.68 Million ≈ $-1.19 Million USD) by net assets (AU$3.35 Million ≈ $2.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Truscreen Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Truscreen Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Truscreen Group Ltd (TRU) total liabilities for a breakdown of total debt and financial obligations.

Truscreen Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Truscreen Group Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Spago Nanomedical AB
ST:SPAGO
-0.201x
Ace Digital AS
OL:ACED
N/A
National Plastic Co Ltd Preferred
KO:004255
0.027x
GENINCODE PLC LS -01
F:9PL
N/A
Sky Quarry Inc
NASDAQ:SKYQ
-0.229x
Ho Hup Construction Company
KLSE:5169
0.004x
Noble Mineral Exploration Inc
V:NOB
-0.094x
Gasporox AB (publ)
ST:GPX
-0.009x

Annual Cash Flow Conversion Efficiency for Truscreen Group Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Truscreen Group Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Truscreen Group Ltd (TRU) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$1.01 Million
≈ $713.49K
AU$-2.29 Million
≈ $-1.62 Million
-2.270x -260.88%
2023-12-31 AU$3.23 Million
≈ $2.29 Million
AU$-2.03 Million
≈ $-1.44 Million
-0.629x +27.11%
2022-12-31 AU$2.54 Million
≈ $1.80 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.863x -15.73%
2021-12-31 AU$3.40 Million
≈ $2.40 Million
AU$-2.53 Million
≈ $-1.79 Million
-0.746x -285.20%
2020-12-31 AU$11.31 Million
≈ $8.00 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.194x +14.24%
2019-12-31 AU$7.24 Million
≈ $5.12 Million
AU$-1.63 Million
≈ $-1.16 Million
-0.226x +4.59%
2018-12-31 AU$11.32 Million
≈ $8.01 Million
AU$-2.68 Million
≈ $-1.90 Million
-0.237x +26.31%
2017-12-31 AU$11.62 Million
≈ $8.22 Million
AU$-3.73 Million
≈ $-2.64 Million
-0.321x -78.55%
2016-12-31 AU$14.32 Million
≈ $10.14 Million
AU$-2.58 Million
≈ $-1.82 Million
-0.180x -284.17%
2015-12-31 AU$14.15 Million
≈ $10.01 Million
AU$-662.10K
≈ $-468.48K
-0.047x +69.78%
2014-12-31 AU$9.86 Million
≈ $6.97 Million
AU$-1.53 Million
≈ $-1.08 Million
-0.155x -321.40%
2013-12-31 AU$10.40 Million
≈ $7.36 Million
AU$-382.34K
≈ $-270.53K
-0.037x --

About Truscreen Group Ltd

AU:TRU Australia Medical Devices
Market Cap
$8.46 Million
AU$11.96 Million AUD
Market Cap Rank
#27273 Global
#1393 in Australia
Share Price
AU$0.02
Change (1 day)
+6.67%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$0.16
About

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more